4//SEC Filing
Lalach Harvey 4
Accession 0001140361-11-011700
CIK 0001314052other
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 8:02 PM ET
Size
9.4 KB
Accession
0001140361-11-011700
Insider Transaction Report
Form 4
Lalach Harvey
DirectorPresident CEO CFO
Transactions
- Sale
common stock
2011-02-18$3.75/sh−3,000$11,250→ 597,000 total - Sale
common stock
2011-02-18$3.74/sh−1,628$6,089→ 595,372 total
Holdings
- 600,000
common stock
- 150,000
stock options
Exercise: $3.10From: 2008-06-03Exp: 2013-06-03→ common stock (150,000 underlying) - 200,000
stock options
Exercise: $3.50From: 2010-06-29Exp: 2015-06-29→ common stock (50,000 underlying)
Documents
Issuer
ANAVEX LIFE SCIENCES CORP.
CIK 0001314052
Entity typeother
Related Parties
1- filerCIK 0001360545
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 8:02 PM ET
- Size
- 9.4 KB